Dash Bio Closes $6.5 Million Seed Financing Round

In The News
October 28, 2024
Attorneys:

Ropes & Gray represented Dash Bio in a $6.5 million seed financing round led by Freestyle Capital. Swift Ventures, LifeX Ventures and other private investors participated in the round, which was announced by press release on Oct. 24.

Ropes & Gray worked with Dash Bio’s founders, who previously worked in data analytics and AI at Moderna, to form the company.

Dash Bio is rebuilding drug development from the ground up by leveraging AI, robotics, and fully-integrated software to fundamentally reinvent the way drugs are brought to market.

The team was led by venture capital & emerging companies partner Brad Flint and venture capital & emerging companies associate Joe Muller.